• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病与右半结肠癌和左半结肠癌风险:前瞻性队列的荟萃分析

Diabetes and Risks of Right-Sided and Left-Sided Colon Cancer: A Meta-Analysis of Prospective Cohorts.

作者信息

Xiao Wenxuan, Huang Jinglong, Zhao Chuanyi, Ding Lu, Wang Xuan, Wu Bian

机构信息

Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Oncol. 2022 Apr 7;12:737330. doi: 10.3389/fonc.2022.737330. eCollection 2022.

DOI:10.3389/fonc.2022.737330
PMID:35463382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9021717/
Abstract

BACKGROUND AND AIMS

Diabetes is associated with an increased risk of colon cancer (CC). Epidemiologic studies previously reported a higher risk for right-sided colon cancer (RCC) compare to left-sided colon cancer (LCC), although data are conflicting. We performed a meta-analysis to investigate this issue.

METHODS

We systematically searched the PubMed, EMBASE, Web of Science and Cochrane Library database for prospective cohort studies published up to June 2021. Studies were included if they reported site-specific estimates of the relative risk (RR) between diabetes and the risks of RCC and LCC. Random effects meta-analyses with inverse variance weighting were used to estimate the pooled site-specific RRs and the RCC-to-LCC ratio of RRs (RRRs).

RESULTS

Data from 10 prospective cohort studies, representing 1,642,823 individuals (mainly white) and 17,624 CC patients, were included in the analysis. Diabetes was associated with an increased risk of both RCC (RR =1.35, 95% CI = 1.24-1.47) and LCC (RR = 1.18, 95% CI = 1.08-1.28). After adjusting for major risk factors, individuals with diabetes had a greater risk for RCC than for LCC (RRR = 1.13, 95% CI = 1.02-1.26), with no significant heterogeneity between studies (I = 0%).

CONCLUSIONS

This meta-analysis indicates that diabetes is associated with a higher risk for RCC than for LCC. Our findings suggest that colonoscopic surveillance in diabetic patients with careful examination of the right colon is warranted.

摘要

背景与目的

糖尿病与结肠癌(CC)风险增加相关。既往流行病学研究报告称,与左侧结肠癌(LCC)相比,右侧结肠癌(RCC)风险更高,尽管数据存在冲突。我们进行了一项荟萃分析以研究此问题。

方法

我们系统检索了截至2021年6月发表的PubMed、EMBASE、科学网和考克兰图书馆数据库中的前瞻性队列研究。如果研究报告了糖尿病与RCC和LCC风险之间特定部位的相对风险(RR)估计值,则纳入研究。采用随机效应荟萃分析和逆方差加权法来估计汇总的特定部位RRs以及RRs的RCC与LCC比值(RRRs)。

结果

分析纳入了10项前瞻性队列研究的数据,涉及1,642,823人(主要为白人)和17,624例CC患者。糖尿病与RCC(RR = 1.35,95%CI = 1.24 - 1.47)和LCC(RR = 1.18,95%CI = 1.08 - 1.28)风险增加均相关。在调整主要危险因素后,糖尿病患者患RCC的风险高于LCC(RRR = 1.13,95%CI = 1.02 - 1.26),研究间无显著异质性(I² = 0%)。

结论

这项荟萃分析表明,糖尿病与RCC风险高于LCC相关。我们的研究结果提示,对糖尿病患者进行结肠镜检查并仔细检查右半结肠是必要的。

相似文献

1
Diabetes and Risks of Right-Sided and Left-Sided Colon Cancer: A Meta-Analysis of Prospective Cohorts.糖尿病与右半结肠癌和左半结肠癌风险:前瞻性队列的荟萃分析
Front Oncol. 2022 Apr 7;12:737330. doi: 10.3389/fonc.2022.737330. eCollection 2022.
2
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis.左半结肠癌与右半结肠癌的预后生存情况:一项系统评价与荟萃分析
JAMA Oncol. 2017 Feb 1;3(2):211-219. doi: 10.1001/jamaoncol.2016.4227.
3
Prognostic value of primary tumor location in colorectal cancer: an updated meta-analysis.结直肠癌原发肿瘤位置的预后价值:一项更新的荟萃分析。
Clin Exp Med. 2023 Dec;23(8):4369-4383. doi: 10.1007/s10238-023-01120-2. Epub 2023 Jul 5.
4
Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.右侧结肠癌与左侧结肠癌患者血小板与淋巴细胞比值的临床基线和预后差异。
BMC Cancer. 2017 Dec 20;17(1):873. doi: 10.1186/s12885-017-3862-8.
5
Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location.全身性免疫炎症指数作为结直肠癌的预后生物标志物及其与原发肿瘤位置的变化关系。
World J Gastroenterol. 2024 Sep 7;30(33):3823-3836. doi: 10.3748/wjg.v30.i33.3823.
6
Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.整合单细胞 RNA 测序和批量 RNA 测序数据对左、右侧结肠癌的预后、肿瘤免疫微环境和药物治疗反应进行比较分析。
Aging (Albany NY). 2023 Jul 21;15(14):7098-7123. doi: 10.18632/aging.204894.
7
Clinicopathological differences and correlations between right and left colon cancer.左右结肠癌的临床病理差异及相关性
World J Clin Cases. 2020 Apr 26;8(8):1424-1443. doi: 10.12998/wjcc.v8.i8.1424.
8
A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer.一项全国性的丹麦队列研究对结肠癌的右半侧和左半侧分类提出了挑战。
BMJ Open. 2013 May 28;3(5):e002608. doi: 10.1136/bmjopen-2013-002608.
9
Molecular heterogeneity of guanine nucleotide binding-protein γ subunit 4 in left- and right-sided colon cancer.左右侧结肠癌中鸟嘌呤核苷酸结合蛋白γ亚基4的分子异质性
Oncol Lett. 2020 Dec;20(6):334. doi: 10.3892/ol.2020.12197. Epub 2020 Oct 7.
10
Colon Cancer Sidedness, Presentation, and Survival at Different Stages.不同阶段结肠癌的发病部位、临床表现及生存率
J Oncol. 2019 Feb 21;2019:4315032. doi: 10.1155/2019/4315032. eCollection 2019.

引用本文的文献

1
Age-specific trends in colorectal, appendiceal, and anal tumour incidence by histological subtype in Australia from 1990 to 2020: a population-based time-series analysis.1990年至2020年澳大利亚按组织学亚型划分的结直肠、阑尾和肛门肿瘤发病率的年龄特异性趋势:基于人群的时间序列分析。
medRxiv. 2025 Apr 24:2025.04.21.25326138. doi: 10.1101/2025.04.21.25326138.
2
A Comprehensive Review of the Effects of Diabetes Mellitus on the Gastrointestinal System.糖尿病对胃肠系统影响的综合综述
Cureus. 2025 Jan 22;17(1):e77845. doi: 10.7759/cureus.77845. eCollection 2025 Jan.
3
Metformin's role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study.

本文引用的文献

1
Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK/mTOR pathway.钠-葡萄糖协同转运蛋白-2(SGLT-2)抑制通过 AMPK/mTOR 通路减少葡萄糖摄取,诱导乳腺癌细胞生长停滞。
Biomed Pharmacother. 2020 Dec;132:110821. doi: 10.1016/j.biopha.2020.110821. Epub 2020 Oct 14.
2
Personal History of Diabetes as Important as Family History of Colorectal Cancer for Risk of Colorectal Cancer: A Nationwide Cohort Study.糖尿病个人史与结直肠癌家族史对结直肠癌风险同样重要:一项全国性队列研究。
Am J Gastroenterol. 2020 Jul;115(7):1103-1109. doi: 10.14309/ajg.0000000000000669.
3
二甲双胍在南方社区队列研究中降低糖尿病患者结直肠癌风险的作用。
Cancer Epidemiol. 2024 Jun;90:102566. doi: 10.1016/j.canep.2024.102566. Epub 2024 Mar 21.
4
Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis.血糖特征与韩国患者结直肠癌生存的关系:一项基于孟德尔随机化的分析。
Cancer Med. 2024 Mar;13(5):e7084. doi: 10.1002/cam4.7084.
5
Association between diabetes at different diagnostic ages and risk of cancer incidence and mortality: a cohort study.不同诊断年龄的糖尿病与癌症发病和死亡风险的关系:一项队列研究。
Front Endocrinol (Lausanne). 2023 Oct 11;14:1277935. doi: 10.3389/fendo.2023.1277935. eCollection 2023.
6
Colorectal Cancer: From Risk Factors to Oncogenesis.结直肠癌:从风险因素到致癌机制。
Medicina (Kaunas). 2023 Sep 12;59(9):1646. doi: 10.3390/medicina59091646.
7
The Frailty Index and colon cancer: a 2-sample Mendelian-randomization study.衰弱指数与结肠癌:一项双样本孟德尔随机化研究。
J Gastrointest Oncol. 2023 Apr 29;14(2):798-805. doi: 10.21037/jgo-23-134.
8
Prognostic Impact of Type 2 Diabetes in Metastatic Colorectal Cancer.2型糖尿病对转移性结直肠癌的预后影响
Cureus. 2023 Jan 18;15(1):e33916. doi: 10.7759/cureus.33916. eCollection 2023 Jan.
9
Cancer and diabetes co-occurrence: A national study with 44 million person-years of follow-up.癌症与糖尿病共病:一项随访 4400 万人年的全国性研究。
PLoS One. 2022 Nov 28;17(11):e0276913. doi: 10.1371/journal.pone.0276913. eCollection 2022.
10
Pro-tumorigenic role of type 2 diabetes-induced cellular senescence in colorectal cancer.2型糖尿病诱导的细胞衰老在结直肠癌中的促肿瘤作用
Front Oncol. 2022 Aug 18;12:975644. doi: 10.3389/fonc.2022.975644. eCollection 2022.
Rethinking the Relationship between Insulin and Cancer.
重新思考胰岛素与癌症之间的关系。
Trends Endocrinol Metab. 2020 Aug;31(8):551-560. doi: 10.1016/j.tem.2020.05.004. Epub 2020 Jun 26.
4
Type 1 diabetes-early life origins and changing epidemiology.1 型糖尿病的早期生活起源和不断变化的流行病学。
Lancet Diabetes Endocrinol. 2020 Mar;8(3):226-238. doi: 10.1016/S2213-8587(19)30412-7. Epub 2020 Jan 27.
5
Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity.达格列净抑制细胞黏附至 I 型胶原和 IV 型胶原,并通过增加 ADAM10 活性增加 DDR1 的胞外结构域蛋白水解切割。
Molecules. 2020 Jan 23;25(3):495. doi: 10.3390/molecules25030495.
6
SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia.钠-葡萄糖协同转运蛋白2(SGLT2)抑制通过逆转高胰岛素血症减缓小鼠肿瘤生长。
Cancer Metab. 2019 Dec 11;7:10. doi: 10.1186/s40170-019-0203-1. eCollection 2019.
7
Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects.二甲双胍在结直肠癌中的作用:分子机制、临床前和临床方面。
J Exp Clin Cancer Res. 2019 Dec 12;38(1):491. doi: 10.1186/s13046-019-1495-2.
8
Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes.2型糖尿病患者结直肠癌风险的性别和部位特异性差异。
Int J Colorectal Dis. 2019 Feb;34(2):269-276. doi: 10.1007/s00384-018-3191-7. Epub 2018 Nov 12.
9
Metformin and Colorectal Cancer.二甲双胍与结直肠癌
Front Endocrinol (Lausanne). 2018 Oct 23;9:622. doi: 10.3389/fendo.2018.00622. eCollection 2018.
10
Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study.10 个欧洲国家结直肠癌风险因素的解剖部位异质性:一项跨国队列研究。
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1323-1331.e6. doi: 10.1016/j.cgh.2018.07.030. Epub 2018 Jul 26.